Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of Internal Medicine

• Publication date

  2009-06-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-150-11-200906020-00118PMID 19380837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES

  2010cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009influential reference
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches

  2009cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial

  2008cited by this paper
• The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes.

  2008cited by this paper
• Self monitoring of blood glucose: the cost to patients

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Effect of a multifactorial intervention on mortality in type 2 diabetes.

  2008cited by this paper
• Cardiovascular outcomes in trials of oral diabetes medications: a systematic review.

  2008cited by this paper
• Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial

  2008cited by this paper
• Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

  2007cited by this paper
• Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial

  2007cited by this paper
• Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

  2006cited by this paper
• Secondary Prevention of Macro Vascular Events in Patients With Type II Diabetes in the PROactive Study (PROspective Pioglitazone Clinical Trial and Macro Vascular Events): A Randomised Controlled Trial

  2006cited by this paper
• Randomized trials stopped early for benefit: a systematic review.

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

  2003cited by this paper
• Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

  2000cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper

• Codesigning a Digital Type 2 Diabetes Risk Communication Tool in Singapore: Qualitative Participatory Action Research Approach

  2023cites this paper
• Continuous Glucose Monitoring and Other Wearable Devices to Assess Hypoglycemia among Older Adult Outpatients with Diabetes Mellitus

  2022cites this paper
• Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes

  2021cites this paper
• Quality of life, burden of treatment, safety, and avoidance of future events (QBSAfe) protocol: a pilot study testing an intervention to shift the paradigm of diabetes care

  2021cites this paper
• Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin.

  2021cites this paper
• Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs

  2021cites this paper
• Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes

  2020cites this paper
• Predictive modeling of hypoglycemia for clinical decision support in evaluating outpatients with diabetes mellitus

  2019cites this paper
• DIABETES LANDMARK OUTCOME TRIALS- Glycemic Control & Prevention Summary

  2019cites this paper
• Measuring Diabetes Quality of Care: Clinical Outcomes, Cost-Effectiveness, and Patient Experience of Care

  2019cites this paper
• The relationship between demographic and anthropometric characteristics and diabetic complications and number of hospitalizations in hospitalized diabetic patients

  2019cites this paper
• Benefits and harms of intensive glycemic control in patients with type 2 diabetes

  2019cites this paper
• Trials Mean follow-up Population Risk , hx , age Intervention A 1 C : baseline final Results Summary of RCT Outcome Evidence

  2019cites this paper
• Association of glucose control and stages of change for multiple self-management behaviors in patients with diabetes: A latent profile analysis.

  2019cites this paper
• Corporate Logic in Clinical Care: The Case of Diabetes Management.

  2019cites this paper
• Language-concordant automated telephone queries to assess medication adherence in a diverse population: a cross-sectional analysis of convergent validity with pharmacy claims

  2018cites this paper
• Diagnostic Test Schirmer and Tear Break Up Time (TBUT) in Uncontrolled Diabetes Mellitus Patient

  2018cites this paper
• Positive Deviance in Health Care: Beware of Pseudo-Equifinality

  2018cites this paper
• Association between insulin‐induced weight change and CVD mortality: Evidence from a historic cohort study of 18,814 patients in UK primary care

  2018cites this paper
• Hyperglycemia effect on coronary disease in patients with metabolic syndrome evaluated by intracoronary ultrasonography

  2017cites this paper
• An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment

  2017cites this paper
• [Shared decision making in patients with diabetes mellitus].

  2017cites this paper
• Identification of outliers and positive deviants for healthcare improvement: looking for high performers in hypoglycemia safety in patients with diabetes

  2017cites this paper
• Patient-Centered Care or Drug-Centered Care: The Influence of Pharmaceutical Marketing on Medical Science and Public Health

  2017cites this paper
• Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure

  2017cites this paper
• Impact and Feasibility of Personalized Decision Support for Older Patients with Diabetes: A Pilot Randomized Trial

  2017cites this paper
• Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries

  2017cites this paper
• Insulin Therapy Increases Cardiovascular Risk: Time for a Sea of Change in Type 2 Diabetes Treatment

  2017cites this paper
• Pathophysiological Construct of Diabetes and its Complications

  2017cites this paper
• Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes.

  2017cites this paper
• Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.

  2016cites this paper
• Low-density lipoprotein cholesterol goals: still not in patients' best interest

  2016cites this paper
• Hypoglycemia as an indicator of good diabetes care

  2016cites this paper
• Shared decision‐making in the care of individuals with diabetes

  2016cites this paper
• Are Diabetes Care Providers Too Glucocentric?

  2016cites this paper
• What to expect from an evolutionary hypothesis for a human disease: The case of type 2 diabetes.

  2016cites this paper
• Different intensities of glycaemic control for pregnant women with pre-existing diabetes.

  2016cites this paper
• Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice.

  2016cites this paper
• Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients

  2016cites this paper
• A Pilot Study to Assess the Feasibility of the Spanish Diabetes Self-Management Program in the Basque Country

  2016cites this paper
• Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status

  2016cites this paper
• Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy’s safety profile

  2016cites this paper
• Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence

  2016cites this paper
• The political economy of co-ordination challenges in the National Health Service: a postpositivist evaluation of diabetes policy and governance

  2016cites this paper
• Overcoming Overuse One Decision at a Time : An Evidence Based Medicine Approach

  2016cites this paper
• Glucose, cholesterol, and blood pressure: is lower always better for type 2 diabetes?

  2016cites this paper
• Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes.

  2015cites this paper
• WDC15 Basic and Clinical Science Stream to offer extensive coverage on treatment advances 12

  2015cites this paper
• Disease progression in newly diagnosed Type 2 Diabetes Mellitus patients: a statistical analysis using Clinical Practice Research Datalink (CPRD)

  2015cites this paper
• Caregiver Status and Self-Reported Health Status Among African American

  2015cites this paper
• Building the Bridge between Operations and Outcomes

  2015cites this paper
• Undue influences on drugs and device industries distort healthcare research, and practice

  2015cites this paper
• Hypoglycaemia, a global cause for concern.

  2015cites this paper
• Health Economic Evaluation of Type 2 Diabetes Mellitus: A Clinical Practice Focused Review

  2015cites this paper
• Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study.

  2015cites this paper
• Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort

  2015cites this paper
• American Geriatrics Society Identifies Another Five Things That Healthcare Providers and Patients Should Question

  2014cites this paper
• Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

  2014cites this paper
• The pursuit of preventive care for chronic illness: turning healthy people into chronic patients.

  2014cites this paper
• Gender differences in cardiovascular risk factors in incident diabetes.

  2014cites this paper
• Diabetes Health Information Technology Innovation to Improve Quality of Life for Health Plan Members in Urban Safety Net

  2014cites this paper
• Rational Use of Electronic Health Records for Diabetes Population Management

  2014cites this paper
• Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?

  2013cites this paper
• Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: a retrospective study.

  2013cites this paper
• Glucose control in older adults with diabetes mellitus--more harm than good?

  2013cites this paper
• Physical Activity and Mortality in Individuals With Diabetes Mellitus: A Prospective Study and Meta-Analysis

  2013cites this paper
• Exenatide may improve maintenance of HbA1c targets, with less hypoglycaemia, but more early adverse effects when compared with low-dose glimepiride

  2013cites this paper
• Focusing on Symptom Management for Frail Elders with Diabetes: Assessing the Relationship between Glycemic Control and Urinary Incontinence

  2013cites this paper
• Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort

  2013cites this paper
• Five treatments nurses can better direct.

  2013cites this paper
• Structured personal care of type 2 diabetes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP)

  2013cites this paper
• (TRIAD) Insulin Starts Project Getting Under the Skin of Clinical Inertia in Insulin Initiation: The Translating Research Into Action for Diabetes

  2013cites this paper
• Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review

  2013cites this paper
• Changing Diagnostic and Treatment Criteria for Chronic Illness: A Critical Consideration of their Impact on Low-Income Hispanic Patients.

  2013cites this paper
• American Geriatrics Society identifies five things that healthcare providers and patients should question.

  2013cites this paper
• Glucose targets in pregnant women with diabetes: a systematic review and meta-analysis.

  2013cites this paper
• Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program.

  2013cites this paper
• The Flip Side of Performance Measures: Comment on “The Other Side of Quality Improvement in Diabetes for Seniors”

  2012cites this paper
• Guías y recomendaciones para el diagnóstico y manejo de la Diabetes Mellitus

  2012cites this paper
• Glucagon-like peptide-1 agonists

  2012cites this paper
• The implementation of current guidelines regarding the treatment of cardiovascular risk in type 2 diabetics

  2012cites this paper
• Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model

  2012cites this paper
• Oral pharmacologic treatment of type 2 diabetes mellitus.

  2012cites this paper
• Selected lifestyle factors and mortality risk in individuals with diabetes mellitus. Are the associations different from individuals without diabetes

  2012cites this paper
• Glycaemic control: do no harm

  2012cites this paper
• Optimal management of type 2 diabetes: the evidence

  2012cites this paper
• Getting Under the Skin of Clinical Inertia in Insulin Initiation

  2012cites this paper
• Quality of life and patient-perceived difficulties in the treatment of type 2 diabetes.

  2012cites this paper
• The drug industry is a barrier to diabetes care in poor countries

  2012cites this paper
• Child safety, absolute risk, and the prevention paradox.

  2012cites this paper
• Different intensities of glycaemic control for pregnant women with pre-existing diabetes.

  2012cites this paper
• Physical Activity and Mortality in Individuals With Diabetes Mellitus: A Prospective Study and Meta-analysis.

  2012cites this paper
• Public Health Implications of Recommendations to Individualize Glycemic Targets in Adults With Diabetes

  2012cites this paper
• The patient‐perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care

  2012cites this paper
• Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus

  2012cites this paper
• General and gender characteristics of type 2 diabetes mellitus among the younger and older age groups.

  2012cites this paper
• Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes

  2012cites this paper
• The flip side of performance measures: limiting overtreatment.

  2012cites this paper
• Inercia terapéutica en el control glucémico de la diabetes mellitus tipo 2: inconvenientes y ventajas

  2012cites this paper
• Optimizing Care in Diabetes: a Quixotic Challenge

  2012cites this paper